Variable CD34(+) recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic

Donor registries and transplantation societies recommend cryopreservation of unrelated donor hemopoietic progenitor cell (HPC) products before the recipient commences conditioning therapy to mitigate the donor and travel risks associated with the COVID-19 pandemic. However, little is known regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Purtill, Duncan, Antonenas, Vicki, Chiappini, Paul, Tong, Daochen, O’Flaherty, Elizabeth, Bajel, Ashish, Kabani, Karieshma, Larsen, Stephen, Tan, Suikeat, Hutchins, Cheryl, Curtis, David J., Kennedy, Glen A., Watson, Anne-Marie, Bai, LiJun, Greenwood, Matthew, Gottlieb, David J., Hamad, Nada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479963/
https://www.ncbi.nlm.nih.gov/pubmed/32886750
http://dx.doi.org/10.1182/bloodadvances.2020002431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479963/
https://www.ncbi.nlm.nih.gov/pubmed/32886750
http://dx.doi.org/10.1182/bloodadvances.2020002431

Ejemplares similares